Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Azzalure and Restylane for Facial Aesthetics
NCT02297503Phase 4Completed
- Sponsor
- Galderma
- Start
- Nov 2014
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 4 trial of botulinum toxin type A in glabellar lines, sponsored by Galderma. Started Nov 2014; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT02297503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02297503.